- Diflorasone
-
Diflorasone Systematic (IUPAC) name [17-(2-Acetyloxyacetyl)- 6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16- octahydrocyclopenta[a]phenanthren-17-yl] acetate Clinical data Trade names Psorcon AHFS/Drugs.com monograph MedlinePlus a602019 Pregnancy cat. ? Legal status ? Identifiers CAS number 1-13-8 ATC code D07AC10 PubChem CID 71414 DrugBank APRD00921 ChemSpider 64504 UNII T2DHJ9645W KEGG D01327 ChEBI CHEBI:31483 ChEMBL CHEMBL1201380 Chemical data Formula C26H32F2O7 Mol. mass 494.525 g/mol (what is this?) (verify) Diflorasone is a corticosteroid that comes in the form of a cream containing diflorasone diacetate. In is manufactured by E. Fougera & Co. and is used for its anti-inflammatory and anti-itching qualities, like other topical corticosteroids. It is often prescribed for psoriasis and atopic dermatitis, and also for Hailey–Hailey disease. It is considered to be of greater potency compared to other topical corticosteroids.[citation needed]
No long-term animal studies have been done to determine whether diflorasone could have carcinogenic properties.
Women who are breastfeeding their newborns should probably not use diflorasone since corticosteroids have been known to appear in breast milk and cause negative effects in a newborn,[citation needed] such as inhibited growth, but little data is available regarding whether topical corticosteroids like diflorasone would be present in great enough quantities to cause harm to an infant.
This dermatologic drug article is a stub. You can help Wikipedia by expanding it.